» Articles » PMID: 26009635

Reduced Glomerular Size Selectivity in Late Streptozotocin-induced Diabetes in Rats: Application of a Distributed Two-pore Model

Overview
Journal Physiol Rep
Specialty Physiology
Date 2015 May 27
PMID 26009635
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Microalbuminuria is an early manifestation of diabetic nephropathy. Potential contributors to this condition are reduced glomerular filtration barrier (GFB) size- and charge selectivity, and impaired tubular reabsorption of filtered proteins. However, it was recently reported that no significant alterations in charge selectivity of the GFB occur in early experimental diabetic nephropathy. We here aimed at investigating the functional changes in the GFB in long-term type-1 diabetes in rats, applying a novel distributed two-pore model. We examined glomerular permeability in 15 male Wistar rats with at least 3 months of streptozotocin (STZ)-induced diabetes (blood glucose ∼20 mmol/L) and in age-matched control rats. The changes in glomerular permeability were assessed by determining the glomerular sieving coefficients (θ) for FITC-Ficoll (molecular radius 20-90 Å) using size exclusion HPLC. The values of θ for FITC-Ficoll of radius >50 Å were significantly increased in STZ-diabetic rats compared to age-matched controls (θ for 50-69 Å = 0.001 vs. 0.0002, and θ for 70-90 Å = 0.0007 vs. 0.00006, P < 0.001), while θ for FITC-Ficoll <50 Å tended to be lower in diabetic rats than in controls (θ for 36-49 Å = 0.013 vs. 0.016, ns). According to the distributed two-pore model, there was primarily an increase in macromolecular transport through large pores in the glomerular filter of diabetic rats associated with a loss of small-pore area. Deterioration in the glomerular size selectivity due to an increase in the number and size-spread of large pores, with no changes in the permeability of the small-pore system, represent the major functional changes observed after 3 months of induced experimental diabetes.

Citing Articles

Application of Nanomaterial-Mediated Ferroptosis Regulation in Kidney Disease.

Zhu J, Zhang Z, Chu Y, Xie Z, Zeng D, Jin L Int J Nanomedicine. 2025; 20:1637-1659.

PMID: 39931533 PMC: 11808220. DOI: 10.2147/IJN.S496644.


The complexity of kidney disease and diagnosing it - cystatin C, selective glomerular hypofiltration syndromes and proteome regulation.

Malmgren L, Oberg C, den Bakker E, Leion F, Siodmiak J, Akesson A J Intern Med. 2022; 293(3):293-308.

PMID: 36385445 PMC: 10107454. DOI: 10.1111/joim.13589.


Potential relationship between eGFR /eGFR -ratio and glomerular basement membrane thickness in diabetic kidney disease.

Oberg C, Lindstrom M, Grubb A, Christensson A Physiol Rep. 2021; 9(13):e14939.

PMID: 34254743 PMC: 8276256. DOI: 10.14814/phy2.14939.


Improving kidney targeting: The influence of nanoparticle physicochemical properties on kidney interactions.

Huang Y, Wang J, Jiang K, Chung E J Control Release. 2021; 334:127-137.

PMID: 33892054 PMC: 8192458. DOI: 10.1016/j.jconrel.2021.04.016.

References
1.
Venturoli D, Rippe B . Ficoll and dextran vs. globular proteins as probes for testing glomerular permselectivity: effects of molecular size, shape, charge, and deformability. Am J Physiol Renal Physiol. 2005; 288(4):F605-13. DOI: 10.1152/ajprenal.00171.2004. View

2.
Oberg C, Rippe B . A distributed two-pore model: theoretical implications and practical application to the glomerular sieving of Ficoll. Am J Physiol Renal Physiol. 2014; 306(8):F844-54. DOI: 10.1152/ajprenal.00366.2013. View

3.
Haraldsson B, Nystrom J . The glomerular endothelium: new insights on function and structure. Curr Opin Nephrol Hypertens. 2012; 21(3):258-63. DOI: 10.1097/MNH.0b013e3283522e7a. View

4.
Lemley K, Blouch K, Abdullah I, Boothroyd D, Bennett P, Myers B . Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol. 2000; 11(11):2095-2105. DOI: 10.1681/ASN.V11112095. View

5.
Remuzzi A, Perico N, Amuchastegui C, Malanchini B, Mazerska M, Battaglia C . Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes. J Am Soc Nephrol. 1993; 4(1):40-9. DOI: 10.1681/ASN.V4140. View